OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/11/2025
Back to search
Official data from USPTO
ENVYTREQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
05/08/2024
Registration date
02/25/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
WILLIS, ALLYSON B
Law office
M40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
Kathryn M. Eyster Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular systemmusculoskeletal systemcentral nervous systemperipheral nervous systemgenitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disordersdamaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparationscell based immune therapeutics for treatment of cancerfor treatment of immunological diseasestreatment of infectious diseases.
Publications
History of USPTO decisions and trademark events.
26 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/26/2025
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
09/27/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/05/2025
FIMP
FINAL DISPOSITION PROCESSED
09/05/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/26/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/25/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
RFNT
REFUSAL PROCESSED BY IB
12/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/05/2024
RFRR
REFUSAL PROCESSED BY MPU
12/05/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/21/2024
CNRT
NON-FINAL ACTION WRITTEN
11/20/2024
DOCK
ASSIGNED TO EXAMINER
11/19/2024
MAFR
APPLICATION FILING RECEIPT MAILED
08/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/24/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/27/2024
Continuous trademark protection
Get notified about every new filing that threatens ENVYTREQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.